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The Functional c.-2G>C Variant of the Mineralocorticoid
Receptor Modulates Blood Pressure, Renin, and
Aldosterone Levels
Nienke van Leeuwen, Massimiliano Caprio, Carolina Blaya, Fre´de´ric Fumeron, Paola Sartorato,
Vanessa Ronconi, Gilberta Giacchetti, Franco Mantero, Fabio L. Fernandes-Rosa, Christophe Simian,
Se´vrine Peyrard, Frans G. Zitman, Brenda W.J.H. Penninx, E. Ron de Kloet, Michel Azizi,
Xavier Jeunemaitre, Roel H. DeRijk, Maria-Christina Zennaro
Abstract—The mineralocorticoid receptor (MR) is essential in the regulation of volemia and blood pressure. Rare
mutations in the MR gene cause type 1 pseudohypoaldosteronism and hypertension. In this study we characterized the
common MR polymorphism c.-2GC (rs2070951) in vitro and tested its influence on parameters related to blood
pressure regulation and the renin-angiotensin system. In vitro studies showed that the G allele was associated with
decreased MR protein levels and reduced transcriptional activation compared with the C allele. Association studies were
performed with several outcome variables in 3 independent cohorts: a mild hypertensive group subjected to a
salt-sensitivity test, a healthy normotensive group included in a crossover study to receive both a high and low Na/K
diet, and a large cohort (The Netherlands Study of Depression and Anxiety), in which blood pressure was measured.
Subjects with the GG genotype had significantly higher plasma renin levels both in the mild hypertensive group and in
normal volunteers compared with homozygous C carriers. The GG genotype was also correlated with higher plasma
aldosterone levels in healthy subjects. In both the mild hypertensive group and The Netherlands Study of Depression
and Anxiety cohort the genotype GG was associated with higher systolic blood pressure in males. In conclusion, the G
allele of the common functional genetic polymorphism c.-2GC in the MR gene associates with increased activation
of the renin-angiotensin-aldosterone axis and with increased blood pressure, probably related to decreased MR
expression. (Hypertension. 2010;56:995-1002.)
Key Words: mineralocorticoid  aldosterone  hypertension  nuclear receptor  sodium balance
The mineralocorticoid receptor (MR) mediates aldoste-rone effects on electrolyte balance and blood pressure
(BP). Classical MR-expressing tissues include the distal parts
of the nephron, colon, salivary glands, and sweat glands,
where MR regulates transepithelial sodium transport. How-
ever, MRs are also expressed in nonepithelial tissues, includ-
ing the cardiovascular system and the central nervous system;
in these tissues, glucocorticoids represent the predominant
endogenous ligand.1 The MR belongs to the nuclear receptor
superfamily and acts as a ligand-activated transcription factor
regulating expression of a coordinate set of genes ultimately
eliciting physiological aldosterone and cortisol responses.
The gene coding for the human MR, NR3C2, is composed of
10 exons and spans over 400 kb. By means of alternative
promoter use, alternative splicing, use of different transla-
tional start sites, and genetic polymorphisms, considerable
variability in MR function has been observed.2,3
Sodium handling is highly variable between individuals,
and genetic factors are involved in the development of
hypertension.4 Rare mutations of the MR are responsible for
mendelian disorders of renal salt handling associated with
high or low BP. Loss of function mutations of the MR lead to
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type 1 pseudohypoaldosteronism,5,6 whereas the rare activat-
ing mutation S810L leads to juvenile hypertension exacer-
bated by pregnancy.7 Two recent studies showed associations
between more common genetic variations, single nucleotide
polymorphisms (SNPs), in the MR and BP.8,9 Previously we
tested the amino acid changing SNP in exon 2, MRI180V
(rs5522), in vitro and showed that the rs5522 G allele leads to
a lower transactivational capacity.10 However, in a group of
mild hypertensive individuals we did not find an association
with BP and MRI180V,10 and the frequency of the same
polymorphism was similar between hypertensive subjects and
controls from a Brazilian birth cohort.11
MRc.-2GC (rs2070951) is a frequent SNP located in the
5-untranslated (UT) region of the NR3C2 gene, 2 nucleo-
tides upstream of the first translation start site. The C allele of
MRc.-2GC has been associated with lower basal cortisol
levels12 and a decrease in MR-dependent transcriptional activa-
tion in the presence of aldosterone.13 However MRc.-2GC has
not been tested for associations with salt handling, and the
precise mechanism of action of this SNP is currently unclear.
In this study, we first investigated the functionality of
MRc.-2GC by testing its effect on MR protein expression,
its influence on the MR-A/MR-B protein ratio, and the
transactivational activity in vitro with different ligands. We
then assessed the effect of this polymorphism on sodium
handling and regulation of the renin-angiotensin system in
2-well phenotyped groups, a normotensive healthy group
included in a crossover study to receive a low Na-high K or
a high Na-low K diet and in a group of mildly hypertensive
patients exposed to a salt sensitivity (Weinberger) test.
Finally, we tested for an association between BP measures in
a large multisite cohort for depression and anxiety.
Materials and Methods
Transactivation Assays
Rabbit RCSV3 cells derived from a kidney cortical collecting duct14
(kindly provided by Prof P. Ronco, Hoˆpital Tenon, Paris, France)
were grown as described previously15 and transfected using lipo-
fectamine 2000 (Invitrogen) with 0.25 g of pcDNA3 plasmid
containing either MR-2G or MR-2C, 0.625 g of a
GRE2_TATA_luc reporter plasmid plasmid16 and 0.25 g of
pSVgal. The day after transfection, steroids were added at different
concentrations, and 48 hours after transfection, luciferase and
-galactosidase activities were assayed using the Dual-Light System
and the Galacton-Plus Substrate (Applied Biosystems). Results were
standardized for transfection efficiency and expressed as the ratio of
luciferase activity over -galactosidase activity in arbitrary units.
Recombinant plasmids used in this study are presented in Figure
1. For construction of recombinant plasmids and transactivation
assays in COS-1 cells, please see the online Data Supplement at
http://hyper.ahajournals.org.
Protein Expression Studies
For studies investigating the effect of the c.-2GC SNP on protein
synthesis, rabbit RCSV3 cells and COS-7 cells were seeded in 6-well
plates at a density of 3105 cells per well 6 hours before
transfection in fresh medium without any added steroid. Cells were
transfected by the calcium phosphate method with 0.66 g of
plasmids pcDNA3_12G-luc, pcDNA3_12C-luc, pcDNA3_12G-
luc, or pcDNA3_12C-luc. Cotransfection of 0.16 g of pSVgal
(Clontech) was performed to normalize for transfection efficiencies.
Cellular extracts were assayed for luciferase and -galactosidase activ-
ities as described previously.15 Results were expressed as the ratio of
luciferase activity over -galactosidase activity in arbitrary units.
For Western blot, Cos-1 cells were seeded in 6-well plates
(Greiner Bio-One) at 2105 cells per well. The cells were trans-
fected the next day using Transit Cos transfection reagent (Mirus).
Plasmids containing one of the MR variants, for example, MR-2G,
MR-2C, mutated MR only expressing MR-A, mutated MR only
expressing MR-B, or no MR (control), were used at 2 g per well.
Cells were harvested 48 hours after transfection. The Western blots
using primary antibodies MR 1D5, detecting amino acid 1 to 18 and,
therefore, only MR-A, and 2B7, detecting amino acid 64 to 82 and,
therefore, both MR-A and MR-B, (a generous gift by C.E. Gomez-
Sanchez, Division of Endocrinology, University of Mississippi,
Jackson, MS) were performed as described previously17 The differ-
ences in intensity of the MR bands were quantified with ImageJ
(National Institutes of Health, http://rsb.info.nih.gov/ij/).
RNA Isolation and Real-Time Quantitative PCR
For RNA isolation and real-time quantitative PCR procedures, please
see the online Data Supplement.
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Figure 1. Presentation of the sequence context
surrounding the SNP c.-2GC, with the sche-
matic representation of human MR isoforms
MR-A and MR-B and the different chimeric gene
constructs used in this study. A, Alignment of the
Kozak consensus sequence for translation initia-
tion and the sequence upstream of the principal
AUG codon (position 1) of the MR mRNA. The
SNP MRc.-2GC is located at position 2 with
respect to the AUG. The human MR mRNA
sequence is aligned with the rat and mouse MR
mRNAs. B, Schematic representation of the chi-
meric constructs 12luc and 12luc. C, Sche-
matic representation of human MR isoforms
MR-A and MR-B and the location of the antibod-
ies used in Western blot experiments for their
detection.
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Subjects
In all of the studies, respondents provided written informed consent,
and all of the studies were performed in accordance with the
Declaration of Helsinki guidelines.
Mild Hypertensive Group
Ninety Italian white patients (34 women and 56 men; mean age: 46.0
years, mean body mass index: 26.8) with mild essential hyperten-
sion, that is, mean systolic BP (SBP) 152 mm Hg and mean diastolic
BP 97.5 mm Hg were recruited by 9 medical centers. The patients
were taken off antihypertensive medication 14 days before testing.
After a normal sodium diet (150 mmol/d) for 3 days, patients were
subjected to an acute salt-loading (constant rate intravenous infusion
of 2 L of 0.9% NaCl carried out over 4 hours) and salt-depletion
protocol (sodium restriction: 50 mmol plus 3 doses of 37.5 mg of
furosemide) to evaluate the distribution of BP sensitivity to salt.18 If
the difference between the mean arterial pressures at the end of the
salt-loading and salt-depletion periods was greater than the median
(10 mm Hg), the patient was classified as salt sensitive; otherwise,
the patient was considered salt resistant. Twenty-four–hour urinary
sodium excretion, upright plasma aldosterone (after 2 hours of
orthostatism), and plasma renin activity were measured after 3 days
of normal sodium diet (150 mmol/d) just before the salt load.
Postload plasma aldosterone and renin activity were measured 4
hours after the beginning of the salt load. Urine electrolytes analyses,
measurements of plasma renin activity, and plasma aldosterone
concentration were performed as described previously.18
Healthy Group
Forty healthy French white normotensive (BP 140/90 mm Hg in
the supine position after 5 minutes of rest) men (18 to 35 years of
age) were included in a crossover study to receive both a low Na
(20 mmol of NaCl per day) and high K (140 mmol of KCl per
day; low Na-high K diet) diet or high Na (250 mmol of NaCl
per day) and low K (50 mmol of KCl per day; high Na-low K
diet) diet for 1 week. The study design has been described previously
in detail.19 Procedures were in accordance with institutional guide-
lines. Controlled Na/K diet periods were separated by a 7-day
washout period. On the ad libitum Na and K diet at baseline and
on day 7 of each controlled Na/K diet period, blood was sampled
at 9:00 AM in the fasting state after 1 hour of rest in the sitting
position for plasma immunoreactive active and total renin and
plasma aldosterone and atrial natriuretic peptide (ANP) determina-
tions. Urine was collected in two 12-hour periods from 8:00 AM to
8:00 PM and from 8:00 PM to 8:00 AM and was used for hormone and
electrolyte determinations. The methods used for collecting blood
samples and for quantifying plasma active renin, total renin, ANP,
and aldosterone were as described previously.19
Multisite Cohort for Depression and Anxiety
Data were obtained from The Netherlands Study of Depression and
Anxiety, an 8-year longitudinal cohort study that includes 2981
Dutch white participants, aged 18 through 65 years. A detailed
description of the study design and sample has been published
previously.20 Netherlands Study of Depression and Anxiety is a
multisite cohort study to describe the long-term course and conse-
quences of depressive and anxiety disorders in which cardiological
parameters, such as BP, were analyzed.20 Participants were recruited
from different locations in The Netherlands (Amsterdam, Leiden,
and Groningen). For the current study, data were used from the
baseline interviews conducted between September 2004 and Febru-
ary 2007. Of the 2981 participants, 1860 subjects have been
genotyped, and after quality control (described previously21), 1754
subjects (67.9% women; mean age: 42.35 years; SD: 12.49 years)
were included in the study. The cohort consisted predominantly of
subjects with current or remitted anxiety and/or depressive disorders
at time of BP assessment. However, the presence of psychiatric
diagnosis was not associated with BP.
BP was registered by the OMRON IntelliSense Professional
Digital Blood Pressure Monitor, HEM-907XL (Omron Healthcare,
Inc). SBP and diastolic BP were measured twice during supine rest
on the right arm and were averaged over the two measurements. A
correction was made for all of the individuals on hypertensive
medication, which was considered as being used if subjects fre-
quently (50% of days in last month) used antihypertensives (Ana-
tomical Therapeutic Chemical [ATC] code C02), diuretics (ATC
code C03), -blocking agents (ATC code C07), or calcium channel
blockers (ATC code C08). In accordance with earlier studies and
based on the efficacy of antihypertensive drugs in randomized
trials,22,23 we added 10 mm Hg to SBP and 5 mm Hg to diastolic BP
for subjects who used antihypertensives.
Determination of Genotypes
For genotyping procedures, please see the online Data Supplement.
Statistical Analysis
For detailed description of the statistical analyses, please see the
online Data Supplement.
Results
MRc.-2G>C Influences the Transactivation
Activity of the MR
The influence of the MR-2GC SNP on MR function was
measured with an in vitro transactivation assay. RCSV3 and
Cos-1 cells were transfected with plasmids containing either
MR with the2C nucleotide or MR with the2G nucleotide
(Figure 1). Dose-response curves in the presence of aldoste-
rone or cortisol showed significantly higher transcriptional
activity in the presence of the 2C allele than with the 2G
variant in both cell models (RCSV3 cells: P0.001 for both
aldosterone [Figure 2, left] and cortisol [Figure 2, right];
Cos-1 cells: P0.05 for aldosterone [Figure S1, left],
P0.001 for cortisol [Figure S1, right]; please see online
Data Supplement).
MRc.-2G>C Affects Protein Expression
Independent of the 5-UT Region
In the human NR3C2 gene, two 5-UT exons are alternatively
transcribed and generate 2 different mRNAs coding for a
unique MR protein.3 The c.-2GC SNP is located in exon 2,
2 nucleotides upstream of the translation initiation site in the
middle of the Kozak consensus sequence for translational
initiation,24,25 which is highly conserved among the NR3C2
genes from several species (Figure 1A). We have investigated
the influence of the c.-2GC SNP on translational efficiency,
in the context of both 5-UT exons 1 and 1. Chimeric
constructs were generated, with exon 1 or 1 inserted
together with the Kozak sequence containing either G or C
immediately upstream of the coding sequence of the lucif-
erase gene (Figure 1B). Transient transfections were per-
formed in renal RCSV3 cells and in COS-7 cells, the amount
of luciferase activity representing the amount of protein
generated. In the presence of comparable mRNA levels
(please see Figure S2A, available in the online Data Supple-
ment), the C allele was associated with significantly higher
protein levels compared with the G allele, both at 12 and 24
hours posttransfection in RCSV3 cells (P0.0001; Figure
3A); this effect was observed in the presence of both the UT
exons 1 or 1. Interestingly, luciferase activity in the
presence of the UT region 1 was 40% of that observed
with exon 1 (P0.0001). The same difference between the
van Leeuwen et al MR Polymorphism and Blood Pressure Regulation 997
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2 alleles was observed in COS-7 cells (P0.0001; Figure
3B), but only in the presence of the UT region 1.
We then investigated whether the2GC SNP may affect
alternative translation of the previously described human MR
isoforms MR-A and MR-B, generated through the use of
alternative translation initiation sites26 (Figure 1C). Expres-
sion vectors containing MR with either 2C or 2G and
control constructs expressing only MR-A or MR-B were
transiently transfected in Cos-1 cells. The MR mRNA levels
after transfection were similar for MR-2C and MR-2G
(Figure S2B). Two different primary antibodies were used in
Western blots: 1D5 directed against amino acids 1 to 18 to
visualize MR-A, whereas 2B7 (amino acids 64 to 82) detects
both MR-A and -B (Figure 1C). Specificity of the antibodies
was confirmed with the control constructs expressing only
MR-A or only MR-B (Figure S3A and S3B). In Cos-1 cells
transfected with MR-2G or MR-2C, only MR-A was ex-
pressed but not MR-B (Figure S3B). Western blots confirmed
the differences in MR-A protein expression between 2G
and 2C containing constructs (Figure S3C), MR-2C result-
ing in significantly increased MR-A expression (ratio of
MR/tubulin: MR-2G, 0.3000.014; MR-2C, 0.3620.022).
Consequences of MRc.-2G>C on Renal Sodium
Handling and BP Regulation
The MRc.-2GC SNP was determined in subjects from 3
independent groups of patients. Allele and genotype frequen-
cies were not significantly different among the 3 groups
(22	5.36, P	0.07 and 24	6.57, P	0.16, respectively;
Table S1).
Mild Hypertensive Group
After 3 days of high-salt diet (150 mmol/d), plasma renin
activity was significantly higher in mild hypertensive GG
patients compared with the other genotypes (Table 1). In
addition, the GG genotype was associated with significantly
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Figure 2. Aldosterone and cortisol-driven transactivation by MR-2C and MR-2G. Aldosterone (left) and cortisol (right) dose-response
curves of the MRc.-2GC variants on a GRE2-containing promoter in RCSV3 cells. Transactivation curves are displayed as the per-
centage of maximal induction obtained with the 2G (SEM). Results represent at least 2 independent experiments performed in tripli-
cate. *P0.05; **P0.01; ***P0.001.
p<0.0001 p<0.0001
0
20
40
60
80
100
120
140
160
180
200
12 hs 24 hs
1α2G
12 hs
1α2C 1β2G 1β2C
24 hs
p<0.0001 p<0.0001
**
RCSV3 cells COS7 cells
%
 a
ct
iv
ity
 1
α
2G
 a
t 1
2h
%
 a
ct
iv
ity
 1
α
2G
 a
t 1
2h
0
20
40
60
80
100
120
140
160
**
p<0.05
p<0.01
p<0.001
***
*
***
***
1α2G 1α2C 1β2G 1β2C 1α2G 1α2C 1β2G 1β2C 1α2G 1α2C 1β2G 1β2C
A B
*
**
***
Figure 3. Effects of MRc.-2GC on protein expression. Effects of 2GC variants on protein expression were measured with a recom-
binant MR-luciferase construct. Chimeric constructs containing exon 1 (white and dark gray bars) showed a higher luciferase expres-
sion compared with chimeric constructs containing exon 1 (light gray and black bars) in either RCSV3 cells (A) or COS-7 cells (B). The
MR-2C variant (dark gray and black bars) showed a higher luciferase expression compared with the MR-2G variant (white and light
gray bars) in either RCSV3 cells (A) or COS-7 cells (B).
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higher SBP levels in men but not in women (Table S2). No
association of the MRc.-2GC genotypes was found with
other parameters tested in the cohort, such as 24-hour urinary
sodium excretion and plasma aldosterone or plasma aldoste-
rone and plasma renin activity levels after salt loading
(P	0.42 and P	0.49, respectively). After the Weinberger
test, the ratio of salt-sensitive/salt-resistant subjects was not
significantly different among genotypes (21	1.69; P	0.43),
and there was no relationship between the genotypes and BP
response to the salt-sensitivity test (P	0.21; data not shown).
Normotensive Subjects
On the ad libitum Na/K diet, 156 mmol of Na (interquar-
tile range: 126 to 187 mmol) and 68 mmol of K (interquar-
tile range: 59 to 81 mmol) were excreted in the urine in 24
hours. By controlling the Na/K intakes, it was possible to
achieve the desired Na and K balances, as reflected by
24-hour urinary NaCl and KCl excretion rates (Table 2). The
24-hour urinary Na and K excretion levels were identical
for subjects of the 3 genotypes for all of the diets (Table 2).
Plasma active and total renin and aldosterone, as well as
ANP, on the ad libitum Na/K diet were within the
physiological ranges and did not differ according to genotype
(Table 2). As expected, plasma active and total renin and
aldosterone concentrations increased with the low Na-high
K diet and decreased with the high Na-low K diet
(P0.0001 between diets for all of the parameters). The
changes in plasma ANP concentrations were in the opposite
directions (Table 2; P0.0001 between diets). On the high
Na-low K diet, GG subjects had significantly higher levels
of plasma active and total renin and plasma aldosterone
concentrations than CC subjects, with heterozygous GC
subjects presenting intermediate values. A similar trend was
observed on the low Na-high K diet, but differences
between GG and CC genotypes were not significant.
Netherlands Study of Depression and Anxiety Cohort
There was a significant association between SBP and MRc.-2GC
(P	0.041), even after adjustment for confounding factors (Table
S3). GG subjects had significantly higher SBP than GC or CC
subjects (mean SBP for GG: 138.21.9 mm Hg; GC:
137.31.8 mm Hg; CC: 135.21.9 mm Hg). Although we did
not detect a sexgenotype interaction (P	0.36), we performed
a separate analysis for both men and women. The association
with MRc.-2GC and SBP was significant for men but not for
women (Table 3). Men with the GG genotype had significant
higher systolic pressure (5.17 mm Hg) than those with the CC
genotype (P	0.046). SBP among men was 147.021.2 mm Hg
for the GG genotype, 143.817.6 mm Hg for the GC genotype,
and 141.920.6 mm Hg for the CC genotype.
Discussion
In this study we have undertaken the functional analysis of
the c.-2GC polymorphism, a frequent SNP in the NR3C2
gene coding for the MR, and its selective genotyping in
subjects from different groups of subjects. The c.-2GC
variant was associated with differential expression of the MR
in vitro; importantly, in vivo, this SNP influences circulating
levels of plasma aldosterone and renin.
A possible role of the MRc.-2GC polymorphism on
translational efficiency had been suggested based on its
location in the middle of the Kozak consensus sequence for
translational initiation.24 First, we showed with 2 different
endogenous ligands and in 2 different cell lines that MR
translated from a construct carrying a C at position 2 was
associated with a higher transcriptional response in vitro.
These results are in contrast to previous work describing
lower transactivation of a reporter gene by the 2C allele
using aldosterone13; differences in methodology or the cell
line used might explain this discrepancy. Second, using 3
different approaches and 2 different cell lines, including a
kidney collecting duct epithelial cell line, we showed that the
C allele results in more abundant protein expression than the
G allele. Because mRNA expression is not modified by
MRc.-2GC, it is concluded that this polymorphism influ-
ences translation. This is in accordance with data showing
that a C at position 2 is probably more favorable for
translation: comparison of 1534 human transcripts has shown
that the sequence surrounding the initiation codon contains a
C at position 2 in 40% of cases, whereas a G nucleotide is
present in only 18%.25 Furthermore, our results demonstrate
that the 5-UT has no influence on the observed effect of the
SNP. In the presence of both UT exons 1 and 1, the 2C
allele was associated with higher protein translation. How-
ever, protein expression in the presence of the UT region 1
was 40% of that observed with exon 1, indicating that the
sequence of exon 1 is less optimal for translation. Finally,
Western blot experiments showed that the MR-A isoform,
translated from the first translation start, was more abundant
Table 1. Characteristics (MeanSD) or Geometric Mean (95% CI) in 90 Mild Hypertensive Men and Women From the Italian Cohort
According to the MR c.-2G>C Genotype
Italian Cohort,
90 Subjects
Frequency,
%
3 Days of Controlled Salt Intake (150 mmol/d) Weinberger Test
24-h Urinary Sodium
Excretion/Creatinin, mEq
Aldosterone,
ng/dL
Plasma Renin
Activity, ng/mL per h
Salt Resistant
(
BP 10 mmHg), n
Salt Sensitive
(
BP 10 mmHg), n
MR c.-2CC (n	29) 32.2 155.154.3 (n	25) 12.8 (10.1 to 16.2) (n	28) 1.42 (1.07 to 1.88) (n	28) 17 12
MR c.-2GC (n	48) 53.3 172.783.7 (n	39) 12.8 (10.6 to 15.4) (n	47) 1.46 (1.20 to 1.79) (n	47) 21 27
MR c.-2GG (n	13) 14.8 180.150.6 (n	11) 12.9 (9.5 to 17.6) (n	11) 2.25 (1.33 to 3.79) (n	11) 7 6
P 0.69* 0.65* 0.029† 0.43‡
There was no interaction between sex and genotype for any variable. For aldosterone and renin, log values were used in the statistical tests.
*Genotype effect from 2-way (genotype, sex) ANCOVA adjusted for age and body mass index.
†Global test (2 degrees of freedom): 0.10, GG vs CCGC.
‡2	1.69; degrees of freedom	2.
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in the presence of the C allele. However, transient transfec-
tion of MR containing either the 2 C or 2 G allele did not
result in any detectable MR-B protein. As far as we know,
only 1 study reported the MR-B isoform26; in that study
MR-B was detected with an in vitro translation assay. Our
results suggest that MR-B is not translated, at least not in
Cos-1 cells. Given that the Kozak region preceding the
translation start of MR-B is weak, the existence of MR-B in
vivo needs further clarification. Taken together, we conclude
that the C allele increases MR protein expression and,
thereby, the in vitro transcriptional activity of the MR.
The physiopathological relevance of our in vitro results
was tested by studying the association of the MRc.-2GC
polymorphism with parameters of BP regulation and electro-
lyte homeostasis in 2 groups of patients well phenotyped for
BP and the renin-aldosterone axis under different experimen-
tal settings. Individuals carrying the CC genotype in either a
healthy cohort under a high Na-low K diet or a mild
hypertensive cohort had significantly lower plasma renin
concentration/renin activity levels, respectively. In parallel
with the lower renin levels, the CC individuals in the healthy
group also presented lower plasma aldosterone levels. The
observed lower active renin, total renin, and lower aldoste-
rone levels suggest a more efficient tubuloglomerular feed-
back in individuals with the CC genotype. According to the in
vitro results obtained in this study, this effect might be
attributed to more efficient sodium reabsorption because of
higher levels of MR in the distal tubule, which was unmasked
in conditions of low aldosterone synthesis and concentration,
that is, on a high Na-low K diet.27 There were trends in
similar directions for these parameters in the healthy group at
baseline or during the low Na-high K diet, but this did not
reach significance. The absence of significant difference
between genotypes may be attributed to a low power of the
study, which was not initially designed to test the effect of the
MR polymorphism. Finally, both in the mild hypertensive
group and in a large Dutch cohort, male GG carriers had a
higher SBP. Taken together, these results indicate that the CC
Table 2. Biological Characteristics of Normal Volunteers According to the MRc.-2G>C Genotype at
Baseline on Ad Libitum Diet and After 7 Days of High Na-Low K and 7 Days of Low Na-High K Diets
Parameter Baseline High Na-Low K P Low Na-High K
Plasma active renin, pg/mL
CC (n	10) 13.8 [9.7 to 19.7] 5.8 [4.3 to 7.8] * 30.7 [24 to 39.2]
GC (n	21) 14.3 [11.6 to 17.6] 8.4 [6.5 to 11] 38.5 [32.6 to 45.4]
GG (n	9) 15.8 [11.7 to 21.4] 10.9 [6.7 to 17.7] 43.6 [30 to 63.3]
Plasma total renin, pg/mL
CC (n	10) 108.3 [83.2 to 141.1] 62.4 [47.4 to 82] * 142.3 [116 to 174.5]
GC (n	21) 125.4 [106.6 to 147.5] 91.7 [73.8 to 113.9] 169.3 [141.8 to 202.1]
GG (n	9) 112.5 [94.9 to 133.4] 83.2 [62.9 to 110] 156.9 [119.3 to 206.5]
Plasma ANP, pg/mL
CC (n	10) 23.34.6 26.78.9 17.94.2
GC (n	21) 20.64.6 2510.4 16.43.3
GG (n	9) 20.35.5 22.68.4 16.43.8
Plasma aldosterone, pg/mL
CC (n	10) 63.7 [47.7 to 85.1] 25.7 [18.3 to 36.1] * 295.1 [216.4 to 402.5]
GC (n	21) 73 [64.2 to 83.1] 38.6 [31.6 to 47.2] 319.9 [262 to 390.4]
GG (n	9) 69.3 [52.8 to 90.8] 38.5 [30.7 to 48.3] 338.9 [266.1 to 431.5]
24-h urine volume, mL
CC (n	10) 1663 (1227 to 1980) 2092 (1896 to 3110) 2415 (1777 to 3463)
GC (n	21) 1496 (1187 to 1943) 1910 (1540 to 2610) 2123 (1781 to 2711)
GG (n	9) 1563 (1188 to 2286) 2448 (1918 to 2662) 2401 (2259 to 2976)
24-h urinary sodium excretion, mmol/24 h
CC (n	10) 177 (153.6 to 237.5) 277.4 (253.5 to 300.4) 17.2 (13.9 to 20)
GC (n	21) 138.9 (108 to 167.1) 246.2 (218.8 to 278.5) 14.1 (11.7 to 21.9)
GG (n	9) 158.2 (133 to 188) 242.9 (230 to 298) 17.4 (11.3 to 30.6)
24-h urinary potassium excretion, mmol/24 h
CC (n	10) 72.2 (65.8 to 86.6) 36.9 (26 to 47.2) 132.1 (96.5 to 144.9)
GC (n	21) 68.8 (55.3 to 83.1) 39.6 (34.3 to 43.1) 119.9 (106.1 to 140.8)
GG (n	9) 67.4 (57.6 to 72.2) 39.3 (29.9 to 42.6) 111.2 (94.5 to 132)
Data are mean [95% CI], meanSD, or median (interquartile range). P value is between high Na-low K and low Na-high K
diets by ANOVA for plasma parameters and by Kruskall-Wallis test for urine aldosterone excretion.
*Data show a between genotype comparison: P0.05 vs GC and P0.05 vs GG. All other comparisons between genotypes were
not significant.
1000 Hypertension November 2010
 at Vrije on July 11, 2011http://hyper.ahajournals.org/Downloaded from 
carriers may have a more favorable cardiovascular profile as
compared with the GC and GG carriers.
Aldosterone has emerged as a key hormone determining
cardiovascular and renal damage and risk prognosis, in
addition to its role in BP regulation and potassium and
sodium homeostasis. Within the last 10 years, blocking its
effects with MR antagonists has been shown to have benefi-
cial effects in congestive heart failure, especially after myo-
cardial infarction, and proteinuric nephropathies.28,29 Al-
though our results need to be replicated in larger cohorts well
phenotyped for BP and the renin-angiotensin-aldosterone
axis, our data suggest that functional variants of the MR may
be associated not only with different cellular responses to
aldosterone but also, indirectly, with increased aldosterone
levels that may activate both genomic and nongenomic
pathways in nonepithelial target tissues to promote deleteri-
ous cardiovascular effects.
Only male carriers of the MRc.-2GC GG genotype
showed higher BP compared with men with the other geno-
types in the mild hypertensive cohort, the polymorphism not
being associated with BP in women. The same sex-dependent
association was found with SBP in the large-scale Dutch
cohort, suggesting a sexual dimorphism. Many studies have
reported sex-related differences in occurrence and severity of
cardiovascular diseases related to the hormonal status.30
Interestingly, it has been shown that ovarian hormones
positively affect salt sensitivity, protecting premenopausal
women from the development of hypertension. After meno-
pause, responsiveness of renin-angiotensin-aldosterone sys-
tem changes, with a net increase in salt sensitivity.31 In
addition, cortisol responses to stressors are different between
men and women, and, as discussed above, cortisol might have
an effect on epithelial MR as well.
Perspectives
Finding genetic variants involved in the regulation of BP
offers mechanistic insights into the development of hyperten-
sion in the general population and helps in identifying novel
targeted therapeutic strategies to prevent cardiovascular dis-
ease. Rare mutations of the NR3C2 gene result in monogenic
diseases of sodium homeostasis and BP regulation. Our study
provides evidence that frequent polymorphisms of the MR
may exert quantitative effects on the activity of the renin-an-
giotensin-aldosterone axis and BP in the general population,
modulating vulnerability for hypertension. Genotyping the
common MR polymorphism c.-2GC could help in identi-
fying patients prone to develop hypertension and vascular
disease, opening new strategies for prevention or targeted
pharmacological treatment.
Acknowledgments
We thank Stephen B. Harrap for critical reading of the article and
helpful comments.
Sources of Funding
M.C. has been a recipient of fellowships from the Fondation pour la
Recherche Me´dicale, the Fondation Simone et Cino del Duca-Institut
de France, and the University of Rome tor Vergata. This work was
supported by a grant from the Fondation pour la Recherche Me´dicale
and by institutional funding from Institut National de la Sante´ et de la
Recherche Me´dicale, a grant from the Nederlandse Hersenstichting,
Psychiatric Hospital Rivierduinen, and the Royal Netherlands Acad-
emy for Arts and Sciences. The infrastructure for The Netherlands
Study of Depression and Anxiety is funded through the Geestkracht
Program of The Netherlands Organization for Health Research and
Development (Zon-MW, grant 10-000-1002) and is supported by
participating universities and mental health care organizations (VU
University Medical Center, GGZinGeest, Arkin, Leiden University
Medical Center, GGZ Rivierduinen, University Medical Center
Groningen, Lentis, GGZ Friesland, GGZ Drenthe, IQ Healthcare,
Netherlands Institute for Health Services Research, and Netherlands
Institute of Mental Health and Addiction [Trimbos]).
Disclosures
None.
References
1. Funder JW. Reconsidering the roles of the mineralocorticoid receptor.
Hypertension. 2009;53:286–290.
Table 3. Association Analysis of the MR MRc.-2G>C Genotype With Diastolic BP and SBP in the
Dutch Cohort
BP Group MR-2G/C Mean SD P*
Systolic, mm Hg Men (n	563) CC (137) 141.86 20.64 0.046
GC (304) 143.81 17.57
GG (122) 147.03 21.23
Women (n	1191) CC (262) 129.53 22.04 0.195
GC (634) 131.26 18.96
GG (295) 131.03 17.76
Diastolic, mm Hg Men (n	563) CC (137) 83.38 12.24 0.232
GC (304) 84.83 11.07
GG (122) 85.49 12.71
Women (n	1191) CC (262) 79.29 13.17 0.301
GC (634) 80.01 11.41
GG (295) 80.26 11.08
*Genotype effect by general linear model adjusted for age, presence of life events, years of education, smoking,
alcohol abuse/dependence, use of tricyclic antidepressant, use of noradrenergic serotonergic antidepressant, No. of
chronic diseases, and body mass index in each sex separately.
van Leeuwen et al MR Polymorphism and Blood Pressure Regulation 1001
 at Vrije on July 11, 2011http://hyper.ahajournals.org/Downloaded from 
2. Pascual-Le Tallec L, Lombes M. The mineralocorticoid receptor: a
journey exploring its diversity and specificity of action. Mol Endocrinol.
2005;19:2211–2221.
3. Zennaro MC, Keightley MC, Kotelevtsev Y, Conway GS, Soubrier F,
Fuller PJ. Human mineralocorticoid receptor genomic structure and iden-
tification of expressed isoforms. J Biol Chem. 1995;270:21016–21020.
4. Halushka MK, Fan JB, Bentley K, Hsie L, Shen N, Weder A, Cooper R,
Lipshutz R, Chakravarti A. Patterns of single-nucleotide polymorphisms
in candidate genes for blood-pressure homeostasis. Nat Genet. 1999;22:
239–247.
5. Geller DS, Rodriguez-Soriano J, Vallo BA, Schifter S, Bayer M, Chang
SS, Lifton RP. Mutations in the mineralocorticoid receptor gene cause
autosomal dominant pseudohypoaldosteronism type I. Nat Genet. 1998;
19:279–281.
6. Pujo L, Fagart J, Gary F, Papadimitriou DT, Claes A, Jeunemaitre X,
Zennaro MC. Mineralocorticoid receptor mutations are the principal
cause of renal type 1 pseudohypoaldosteronism. Hum Mutat. 2007;28:
33–40.
7. Geller DS, Farhi A, Pinkerton N, Fradley M, Moritz M, Spitzer A,
Meinke G, Tsai FT, Sigler PB, Lifton RP. Activating mineralocorticoid
receptor mutation in hypertension exacerbated by pregnancy. Science.
2000;289:119–123.
8. Tobin MD, Tomaszewski M, Braund PS, Hajat C, Raleigh SM, Palmer
TM, Caulfield M, Burton PR, Samani NJ. Common variants in genes
underlying monogenic hypertension and hypotension and blood pressure
in the general population. Hypertension. 2008;51:1658–1664.
9. Martinez F, Mansego ML, Escudero JC, Redon J, Chaves FJ. Association
of a mineralocorticoid receptor gene polymorphism with hypertension in
a Spanish population. Am J Hypertens. 2009;22:649–655.
10. DeRijk RH, Wust S, Meijer OC, Zennaro MC, Federenko IS, Hellhammer
DH, Giacchetti G, Vreugdenhil E, Zitman FG, de Kloet ER. A common
polymorphism in the mineralocorticoid receptor modulates stress respon-
siveness. J Clin Endocrinol Metab. 2006;91:5083–5089.
11. Fernandes-Rosa FL, Bueno AC, Molina de SR, de CM, Dos Santos JE,
Foss MC, Zennaro MC, Bettiol H, Barbieri MA, Antonini SR. Mineralo-
corticoid Receptor p.I180V polymorphism: association with body mass
index and LDL-cholesterol levels. J Endocrinol Invest. 2010;33:
472–477.
12. Kuningas M, de Rijk RH, Westendorp RGJ, Jolles J, Slagboom PE, van
Heemst D. Mental performance in old age dependent on cortisol and
genetic variance in the mineralocorticoid and glucocorticoid receptors.
Neuropsychopharmacology. 2007;32:1295–1301.
13. Arai K, Nakagomi Y, Iketani M, Shimura Y, Amemiya S, Ohyama K,
Shibasaki T. Functional polymorphisms in the mineralocorticoid receptor
and amirolide-sensitive sodium channel genes in a patient with sporadic
pseudohypoaldosteronism. Hum Genet. 2003;112:91–97.
14. Vandewalle A, Lelongt B, Geniteau-Legendre M, Baudouin B, Antoine
M, Estrade S, Chatelet F, Verroust P, Cassingena R, Ronco P. Mainte-
nance of proximal and distal cell functions in SV40-transformed tubular
cell lines derived from rabbit kidney cortex. J Cell Physiol. 1989;141:
203–221.
15. Zennaro MC, Souque A, Viengchareun S, Poisson E, Lombes M. A new
human MR splice variant is a ligand-independent transactivator modu-
lating corticosteroid action. Mol Endocrinol. 2001;15:1586–1598.
16. Asselin-Labat ML, David M, Biola-Vidamment A, Lecoeuche D,
Zennaro MC, Bertoglio J, Pallardy M. GILZ, a new target for the tran-
scription factor FoxO3, protects T lymphocytes from interleukin-2
withdrawal-induced apoptosis. Blood. 2004;104:215–223.
17. Conway-Campbell BL, McKenna MA, Wiles CC, Atkinson HC, de Kloet
ER, Lightman SL. Proteasome-dependent down-regulation of activated
nuclear hippocampal glucocorticoid receptors determines dynamic
responses to corticosterone. Endocrinology. 2007;148:5470–5477.
18. Strazzullo P, Galletti F, Dessi-Fulgheri P, Ferri C, Glorioso N, Malatino
L, Mantero F, Manunta P, Semplicini A, Ghiadoni L, Zoccali C, for the
Salt-Sensitivity Study Group of the Italian Society of Hypertension.
Prediction and consistency of blood pressure salt-sensitivity as assessed
by a rapid volume expansion and contraction protocol. J Nephrol. 2000;
13:46–53.
19. Azizi M, Boutouyrie P, Bissery A, Agharazii M, Verbeke F, Stern N,
Bura-Riviere A, Laurent S, henc-Gelas F, Jeunemaitre X. Arterial and
renal consequences of partial genetic deficiency in tissue kallikrein
activity in humans. J Clin Invest. 2005;115:780–787.
20. Penninx BW, Beekman AT, Smit JH, Zitman FG, Nolen WA, Spinhoven
P, Cuijpers P, De Jong PJ, van Marwijk HW, Assendelft WJ, van der MK,
Verhaak P, Wensing M, De GR, Hoogendijk WJ, Ormel J, van DR. The
Netherlands Study of Depression and Anxiety (NESDA): rationale,
objectives and methods. Int J Methods Psychiatr Res. 2008;17:121–140.
21. Sullivan PF, de Geus EJ, Willemsen G, James MR, Smit JH, Zandbelt T,
Arolt V, Baune BT, Blackwood D, Cichon S, Coventry WL, Domschke
K, Farmer A, Fava M, Gordon SD, He Q, Heath AC, Heutink P, Holsboer
F, Hoogendijk WJ, Hottenga JJ, Hu Y, Kohli M, Lin D, Lucae S,
Macintyre DJ, Maier W, McGhee KA, McGuffin P, Montgomery GW,
Muir WJ, Nolen WA, Nothen MM, Perlis RH, Pirlo K, Posthuma D,
Rietschel M, Rizzu P, Schosser A, Smit AB, Smoller JW, Tzeng JY, van
DR, Verhage M, Zitman FG, Martin NG, Wray NR, Boomsma DI,
Penninx BW. Genome-wide association for major depressive disorder: a
possible role for the presynaptic protein piccolo. Mol Psychiatry. 2009;
14:359–375.
22. Cui JS, Hopper JL, Harrap SB. Antihypertensive treatments obscure
familial contributions to blood pressure variation. Hypertension. 2003;
41:207–210.
23. Mancia G, Parati G. Office compared with ambulatory blood pressure in
assessing response to antihypertensive treatment: a meta-analysis.
J Hypertens. 2004;22:435–445.
24. Kozak M. Influences of mRNA secondary structure on initiation by
eukaryotic ribosomes. Proc Natl Acad Sci U S A. 1986;83:2850–2854.
25. Peri S, Pandey A. A reassessment of the translation initiation codon in
vertebrates. Trends Genet. 2001;17:685–687.
26. Pascual-Le Tallec L, Demange C, Lombes M. Human mineralocorticoid
receptor A and B protein forms produced by alternative translation sites
display different transcriptional activities. Eur J Endocrinol. 2004;150:
585–590.
27. Menard J, Gonzalez MF, Guyene TT, Bissery A. Investigation of aldo-
sterone-synthase inhibition in rats. J Hypertens. 2006;24:1147–1155.
28. Pitt B. Role of aldosterone blockade in heart failure. Heart Fail Clin.
2005;1:49–56.
29. Mehdi UF, ms-Huet B, Raskin P, Vega GL, Toto RD. Addition of
angiotensin receptor blockade or mineralocorticoid antagonism to
maximal angiotensin-converting enzyme inhibition in diabetic nephrop-
athy. J Am Soc Nephrol. 2009;20:2641–2650.
30. Rosano GM, Vitale C, Marazzi G, Volterrani M. Menopause and cardio-
vascular disease: the evidence. Climacteric. 2007;10(suppl 1):19–24.
31. Schulman IH, Aranda P, Raij L, Veronesi M, Aranda FJ, Martin R. Surgical
menopause increases salt sensitivity of blood pressure. Hypertension. 2006;
47:1168–1174.
1002 Hypertension November 2010
 at Vrije on July 11, 2011http://hyper.ahajournals.org/Downloaded from 
On-line supplement 
 
THE FUNCTIONAL c.-2G>C VARIANT OF THE MINERALOCORTICOID RECEPTOR 
MODULATES BLOOD PRESSURE, RENIN AND ALDOSTERONE LEVELS  
 
Nienke van Leeuwen1*, Massimiliano Caprio2*, Carolina Blaya 3$, Frédéric Fumeron4,5$, Paola 
Sartorato6, Vanessa Ronconi7, Gilberta Giacchetti7, Franco Mantero6, Fabio Luiz Fernandes-
Rosa8,9, Christophe Simian10, Sévrine Peyrard10, Frans G. Zitman11, Brenda W.J.H. Penninx11,12, 
E. Ron de Kloet1, Michel Azizi9,10, Xavier Jeunemaitre8,9,10, Roel H. DeRijk1,11& & Maria-
Christina Zennaro8,9,10&# 
 
 
 at Vrije on July 11, 2011http://hyper.ahajournals.org/Downloaded from 
Data supplement 
 
Construction of the plasmids 
The recombinant pRSV human MR (hMR) plasmid, containing the last 30 base pairs of exon 1α to the 
untranslated region of exon 9, was obtained from Dr. R. Evans (gene expression laboratory and HHMI, 
The Salk Institute for Biological Studies, La Jolla, Ca). The MR c.-2G>C site was mutated from G to C 
with the Quick Change Site Directed Mutagenesis kit (Stratagene, La Jolla, CA) using the primers 5’-
GGCCGAGGCAGCGATGGAGACCAAAG-3’ and 5’-GCTGCCTCGGCCCTTTGGTCTCCAT-3’ 
according to the manufacturers protocol. The plasmids expressing only MR-A or MR-B were generated by 
mutating the second or the first ATG into ATC by using the primers 5’-
CTGAAGGTCTAGATACGGAAAGACGGTGG-3’ and 5’-
CCACCGTCTTTCCGTATCTAGACCTTCAG-3’ or 5’-CCGAGGCAGGGACGGAGACCAAAGG-3’ 
and 5’-CCTTTGGTCTCCGTCCCTGCCTCGG-3’ respectively (Fig. 1c). After mutagenesis the hMR 
insert of the plasmid was sequenced to assure absence of other mutations. Plasmids were purified from 
DH5α E-coli bacterial cultures using the Pure Yield purification system (Promega, Leiden, The 
Netherlands). 
 
To generate pcDNA3_1α2G-luc and pcDNA3_1β2G-luc (Fig. 1a and b), human kidney and 
hippocampus (for pcDNA3_1β2G-luc) cDNA was amplified to generate fragments containing exon 1α or 
1β and 60 bp of exon 2 of the NR3C2 gene. The cDNA coding for luciferase was amplified, starting from 
codon 2, using the pGL2-basic vector (Promega, Madison, WI) as a template. Primers were designed 
containing specific restriction sites for subsequent cloning. All amplification fragments were subcloned 
into pGEMTeasy (Promega). The intermediate constructs pGEMTeasy_1α2 and pGEMTeasy_1β2 were 
digested with SpeI/XbaI, and ligated to the luciferase cDNA previously excised from pGEMTeasy_luc by 
digestion with SpeI. The chimeric construct 1α2luc was excised from pGEMTeasy_1α2luc by digestion 
with BamHI and XhoI and inserted into pcDNA3 (Invitrogen, Paisley, Scotland) to obtain pcDNA3_1α2-
luc and pcDNA3_1β2-luc. Oligonucleotides used for amplification of the different fragments are the 
following: 
1α2 : 5'-ATGGATCCAGAGGAAGCCCGTGCAGTCA 3' and 5'-CCCACCGTCTTTCCATATCT-3' 
1β2 : 5'-ATGGATCCCGCCGCTGCCTCGCCGCCTC-3' and 5'-CCCACCGTCTTTCCATATCT-3' 
Luciferase: 5'-GCACTAGTCGAAGACGCCAAAAACATAAAGA-3' and 5'-
CCCTCGAGCATTTTACAATTTGGACTTTC-3' 
Different pcDNA3_1α2-luc and pcDNA3_1β2-luc clones were sequenced to verify the nucleotide 
rs2070951 (MR c.-2G>C). The G to C change was created by site-directed mutagenesis using the Quick 
change site-directed mutagenesis kit (Strategene, La Jolla, CA) on the recombinant plasmids. The 
following sense primer was used together with their corresponding antisense oligonucleotide. 
 
Transactivation assay COS-1 cells 
Cos-1 cells (African green monkey kidney cells) were cultured as described previously1 and seeded in 
24-well plates (Greiner Bio-One, Alphen a/d Rijn, The Netherlands) at 3 x 104 cells/well in DMEM 
supplemented with charcoal-stripped serum. The cells were transfected the next day using SuperFect 
(Qiagen, Venlo, The Netherlands). Plasmids containing MR-2G or MR-2C or no MR (control) and the 
reporter plasmid TAT3-Luc (tyrosine amino transferase triple hormone response element) were used  at 
200 ng/well. Construction of the plasmids is described in the data supplement available online. The 
control plasmid pCMV-Renilla (Promega, Leiden, The Netherlands) was used  at 2 ng/well. To exclude 
variation due to impurity or concentration of the plasmid each plasmid was cultured 3 times, purified and 
tested. In each of the three experiments the plasmids were tested in quadruplicate. One day after 
transfection, the cells were treated with different concentrations of either aldosterone or cortisol (both 
Sigma-Aldrich, Zwijndrecht, the Netherlands) . After 24h of incubation the cells were harvested in passive 
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lyses buffer (Promega) and firefly and Renilla luciferase activity was determined using the dual label 
reporter assay (Promega) and a luminometer (CentroXS, Berthold, Bad Wildbad, Germany).  
 
 
RNA isolation and real time quantitative PCR 
All reagents used were from Invitrogen unless otherwise specified. Transfections with plasmids containing 
one of the hMR variants, pcDNA3_1α2G-luc, pcDNA3_1α2C-luc, pcDNA3_1β2G-luc, pcDNA3_1β2C-luc 
and pSVβgal were performed as described under the protein expression section. After transfection, total RNA 
was extracted in Trizol reagent according to manufacturer’s recommendations. Total RNA was treated with 
DNase I and quantified with the Ribogreen RNA quantitation kit as previously described 2. 1μg or 500 ng of 
RNA were used to generate cDNA. Amplification of the cDNA was performed using SYBRgreen (qPCR 
MasterMix Plus for SYBR® green I, Eurogentec, Seraing, Belgium) on a Chromo4 Continuous Fluorescence 
Detector (MJ Research, Bio-Rad laboratories, Waltham, MA), according to the manufacturers instructions. 
Primer sequences are available upon request. Controls without reverse transcriptase and without template were 
included to verify that fluorescence was not overestimated by residual genomic DNA amplification or from 
primer dimer formation. Moreover RT-PCR products were analyzed in a post-amplification fusion curve to 
ensure that a single amplicon was obtained. Ribosomal 18S RNA was used to normalize for RNA quality, 
quantity and RT-efficiency. Quantification of βgal was used to normalize for transfection efficiency. 
Quantification was done by the standard curve method. Standard curves were generated by serial dilutions of a 
linearized plasmid containing the specific amplicon, spanning six orders of magnitude, yielding a correlation 
coefficient of at least 0.98 in all experiments. For all experiments, PCR efficiency was close to 2 indicating a 
doubling of DNA at each PCR cycle, as expected. 
 
Determination of genotypes 
 Patients from the Italian cohort were genotyped by direct sequencing after PCR amplification using an 
ABI BigDye termination sequence kit v1.1 (Applied Biosystems Foster City, USA) on an ABI 3700 DNA 
analyzer and the reaction was performed according to the manufacturer’s specifications. Patients from the 
French cohort were genotyped by direct sequencing of PCR products using the ABI Prism Big Dye Terminator 
v3.1 Cycle Sequencing Kit on an ABI Prism 3700 DNA Analyzer. Primers for PCR amplification are Primers 
used for genotyping are: 
Fw  5’-ATA TGT TTT GTG GCT TAG CAA AT-3’ 
Rv  5’AAC TTA GAG TGG AAG GAC GAT GG-3” 
 Subjects from the Dutch NESDA cohort were genotyped by Perlegen Sciences (Mountain View, CA, 
USA) using a set of four proprietary, high-density oligonucleotide array , which had a call rate of 98.9% for 
this SNP. A detailed description of the genotype process is described elsewhere 3. 
 
Statistical analysis 
In cell culture experiments the difference between the two alleles was analyzed with a two-way 
ANOVA with Bonferroni post-hoc tests. For western blot the difference in protein expression was 
analyzed with t-test. In vitro results are shown as the mean ± SD or mean ± SEM. Statistical analysis of all 
the in vitro results was performed with Graph Pad Prism version 5 (GraphPad software Inc, San Diego, 
CA).  
In the Italian mild hypertensive group, the MR genotype effects were assessed using two-way 
(genotype/sex) ANCOVA with age and BMI as covariates. Skewed variables were log-transformed before 
statistical testing. When the interaction between genotype and sex was significant (blood pressure), 
analyses were separately performed in each sex. The statistical analysis was performed using Systat 11 
statistical software.    
In the healthy volunteers group, differences between MR genotype groups were assessed by ANOVA for 
a crossover design for plasma parameters and by non parametric Kruskal-Wallis test for urinary 
parameters. Stata Statistical Software (version 7.0; StataCorp.) was used for statistical analysis.  
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In the Dutch NESDA cohort, differences between MR genotype groups in SBP and DBP were analysed 
using general linear model (GLM).  We tested for gene gender interaction and performed the GLM for the 
entire sample and split for gender. The previous identified confounders related to BP in this cohort: 
gender, age, years of education, alcohol use, smoking, tricyclic antidepressants, noradrenergic and 
serotonergic working antidepressants, number of chronic disease, body mass index, depression and 
anxiety comorbidity and presence of significant life events 4 were included as covariates. SPSS 15.0 was 
used for the statistical analysis. Association study data are expressed as means ± SD or medians and 
interquartile ranges.  
Allele frequencies in the three cohorts were calculated and analyzed for deviation from Hardy-Weinberg 
equilibrium (HWE) using Haploview. The groups consisting of mild hypertensive individuals and of 
healthy individuals did not deviate from HWE, as well as the healthy individuals from the NESDA cohort. 
However, deviation from HWE was observed in the patients with mood and/or anxiety disorders from the 
NESDA cohort (p=0.0053). Deviation from HWE in patients can be interpreted as an indication of 
association of particular genes with disease5, 6. Under these circumstances, the lack of HWE arises as a 
result of selection according to the phenotype that results in allele and genotype distributions that are 
nonrandom. 
Data are expressed as mean ± SD or otherwise specified. A P-value of less than 0.05 was considered to be 
significant. 
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Table S1. Comparison of allele and genotype frequencies in the three different cohorts 
group Allele frequencies  Genotype frequencies 
 C G  CC GC GG 
Hypertensive 0.59 0.41  0.32 0.53 0.15 
Healthy 0.51 0.49  0.25 0.53 0.22 
NESDA 0.51 0.49  0.24 0.53 0.23 
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Table S2.  Association analysis of the MR c.-2G>C genotype with diastolic and systolic blood 
pressure in 90 mild hypertensive men and women from the Italian cohort  
 
 Blood 
pressure 
Group MR-
2G>C 
Mean SD P* 
Systolic 
(mmHg) 
Men (n=56) CC (22) 
GC (26) 
GG (8) 
 
151.5 
147.8 
165.8 
11.6 
12.6 
9.8 
0.004 
Women 
n=34 
CC (7) 
GC (22) 
GG (5) 
 
151.0 
158.1 
141.0 
9.8 
18.9 
8.9 
0.21 
Diastolic 
(mmHg) 
Men (n=56) CC (22) 
GC (26) 
GG (8) 
 
99.1 
96.5 
102.0 
5.1 
6.3 
5.3 
0.053 
Women 
n=34 
CC (7) 
GC (22) 
GG (5) 
95.6 
98.1 
90.0 
8.3 
9.7 
3.5 
0.056 
BP: blood pressure; *genotype effect by ANCOVA adjusted for age and BMI in each sex 
separately.  
Interaction genotype X sex: P = 0.001 and P = 0.005 for PAS and PAD respectively. 
 at Vrije on July 11, 2011http://hyper.ahajournals.org/Downloaded from 
Table S3. Results of General Linear Model with mean systolic pressure (medication adjusted) as outcome in the whole cohort 
(n=1754 subjects), and stratified for gender  
Parameter complete cohort Gender 
 Male (n=563) Female (n=1191) 
 F test P R2 F test P  R2 F test P  R2 
Model   0.263   0.145   0.207 
MR c.-2G>C 3.202 0.041  3.088 0.046  1.639 0.195  
Negative life events, yes vs. no 1.104 0.294  0.327 0.568  0.895 0.344  
Gender, female vs. male 141.204 <0.001        
Age, per 1-year increase 246.499 <0.001  46.926 <0.001  198.771 <0.001  
Years of education, per 1-year increase 5.799 0.016  0.398 0.528  5.556 0.019  
Smoking, yes vs. no 9.603 0.002  8.915 0.003  2.966 0.085  
Alcohol abuse or dependence, yes vs. no 0.728 0.394  0.187 0.665  0.417 0.519  
Use of a TCA, yes vs. no 4.241 0.040  1.439 0.231  2.638 0.105  
Use of NS working antidepressant, yes vs. 
no 
2.711 0.100  0.333 0.564  2.739 0.098  
Number of chronic diseases, per 1 disease 
increased 
11.376 0.001  5.885 0.016  6.001 0.014  
BMI, per 1kg/m2 increase 9.427 0.002  4.747 0.030  5.584 0.018  
Abbreviations: TCA, tricycle antidepressant; NS, noradrenergic serotonergic; BMI, Body Mass Index 
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Figure S1. Aldosterone and cortisol-driven transactivation by MRc.-2C and MRc.-2G in 
COS-1 cells. Aldosterone (a) and cortisol (b) driven transactivation of the MRc.-2G>C variants 
on a TAT-3 promoter in COS-1 cells displayed as percentage of maximal induction obtained with 
-2G (±SEM), Results represent at least two independent experiments performed in triplicate.  
*, p<0.05; **, p<0.01; ***, p<0.001. 
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Figure S2.  Effects of MRc.-2G>C on mRNA expression levels of recombinant proteins used 
in this study. a) Chimeric constructs containing -2G (white and light gray bars) showed no 
significant difference in mRNA expression compared to chimeric constructs containing -2C (dark 
gray and black bars)  after either 12 or 24 hours. The mRNA expression was normalized against 
total RNA and transfection efficiency. b). The MR-2G variant (white bar) showed no significant 
difference in mRNA expression compared with the MR-2G variant (dark gray bar); the mRNA 
expression was normalized against total RNA. 
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Figure S3.  Effects of MRc.-2G>C on the expression of MR isoforms.  Constructs containing MR 
with either -2C or -2G and control constructs expressing only MR-A or MR-B were transiently 
transfected in Cos-1 cells. The effect of the -2G or -2C allele on MR-A and B protein expression was 
measured by Western blot using two different antibodies recognizing aminoacids 1 to 18 (visualizing 
MR-A, Fig. S3a), or aminoacids 64 to 82, detecting both MR-A and B (Fig. S3b). c) Quantification of 
MR expression of multiple experiments using the MR-A detecting antibody (1D5).  
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